Clinical trials recruiting in Bunkyō-Ku, Japan
8
Recruiting trials
15
Conditions
Phase breakdown
Phase 1 1Phase 2 1Phase 3 4Not applicable 2
Conditions recruiting in Bunkyō-Ku, Japan
Recruiting trials in Bunkyō-Ku, Japan
- A Phase III Study of CLS2901C in Patients With Osteoarthritis of the Knee
- A Study of KK2269 in Adult Participants With Solid Tumors
- A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
- Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
- Immediate Necrosectomy vs. Step-up Approach for Walled-off Necrosis
- RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
- Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Common questions
How many clinical trials are recruiting in Bunkyō-Ku, Japan?
8 recruiting trials have at least one study site in Bunkyō-Ku, Japan.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.